« Synthetic Biologics Launches Free Investor Relations Mobile Application – MarketWatch (press release) | Home | Coming May 5: ‘Hackett Clan’ 5K for ALS – Patch.com »
Cytokinetics Announces Presentation of Preclinical Data Regarding CK-2017357 … – MarketWatch (press release)
By | April 26, 2012
 Xconomy |
Cytokinetics Announces Presentation of Preclinical Data Regarding CK-2017357 …
MarketWatch (press release) In addition, CK-2017357 has received Fast Track designation from the US Food and Drug Administration for the potential treatment of ALS. Cytokinetics recently completed a two-part, Phase II safety, tolerability, pharmacokinetic and pharmacodynamic … Cytokinetics Announces Encouraging Results From Two Phase II Clinical Trials …Marketwire (press release) all 13 news articles » |
Topics: Uncategorized | No Comments »